Stevioside

Star0

DB16882InvestigationalSmall molecule

Stevioside: Overview.

Mechanism: Pharmacologically active on Extracellular signal-regulated kinase (ERK)
Curator reviewed
Formula / weight: C₃₈H₆₀O₁₈ · 804.88 g/mol (avg)
Code names: E-960 · FEMA NO. 4763 · INS-960

Resolves to

Compound

UNII0YON5MXJ9PCAS57817-89-7ChEMBLCHEMBL444122ChEBI9271KEGGC09189

Clinical / RWD

RxNorm37106

Structure

InChIKeyUEDUENGHJMELGK-HYDKPPNVSA-NSMILES

[H][C@@]12CC[C@@]3(C[C@]1(CC3=C)CC[C@]1([H])[C@@](C)(CCC[C@@]21C)C(=O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O

What you can answer from here — as of September 25, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of Stevioside, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account